南區 Interstitial Lung Disease 多專科討論會議(實體會議&線上即時會議)
IPF is characterized as a progressive, highly life-threatening interstitial lung disease with unknown etiology. The median survival of patients with IPF is only 2 to 3 years. It occurs primarily in elders, is limited to the lungs, and is defined by the histopathologic and/or radiologic pattern of UIP. It should be considered in all adult patients with unexplained chronic exertional dyspnea, cough, bibasilar inspiratory crackles, and/or digital clubbing that occur without constitutional or other symptoms that suggest a multisystem disease. Patients with IPF may present with an acute exacerbation as an initial manifestation. The disease course is unpredictable and various, so early IPF detection and immediate treatment are crucial to the preservation of patients’ lung function. Beyond IPF, the presentation, diagnosis, and clinical course of Progressive-fibrosing ILD (PF-ILD) have shown the similarity with IPF. PF-ILD usually is associated with autoimmune disease (e.g., SSc-ILD, RA-ILD, DM-ILD, Sjogren syndrome associated ILD), fibrotic chronic hypersensitivity pneumonitis, sarcoidosis or related to occupational environment exposure. In this meeting, we will present the latest IPF/PF-ILD clinical information and differential diagnosis for ILD via multiple disciplinary discussions for your reference.

主辦 / 主持人:
台灣百靈佳殷格翰(股)有限公司
積分:
B類2分
聯絡人:
邱瓊茹
0905889135
活動日期:
2020-03-28 15:00 ~ 18:30
地點:
高雄漢來大飯店_15 樓 會議廳( (高雄市成功一路 266 號)
參加對象:
主辦單位所屬院內醫師